S&P 500   3,380.24 (+0.51%)
DOW   27,814.12 (+0.12%)
QQQ   282.10 (+1.53%)
AAPL   116.65 (+0.73%)
MSFT   213.12 (+1.33%)
FB   267.53 (+2.15%)
GOOGL   1,486.55 (+1.43%)
AMZN   3,203.89 (+1.75%)
TSLA   446.18 (+4.00%)
NVDA   544.31 (+0.57%)
BABA   290.38 (-1.22%)
CGC   14.11 (-1.47%)
MU   47.79 (+1.77%)
GE   6.17 (-0.96%)
AMD   84.89 (+3.54%)
T   28.47 (-0.14%)
F   6.71 (+0.75%)
ACB   4.72 (+1.51%)
GILD   63.48 (+0.46%)
NFLX   519.66 (+3.93%)
DIS   123.51 (-0.46%)
BA   166.86 (+0.97%)
BAC   24.04 (-0.21%)
S&P 500   3,380.24 (+0.51%)
DOW   27,814.12 (+0.12%)
QQQ   282.10 (+1.53%)
AAPL   116.65 (+0.73%)
MSFT   213.12 (+1.33%)
FB   267.53 (+2.15%)
GOOGL   1,486.55 (+1.43%)
AMZN   3,203.89 (+1.75%)
TSLA   446.18 (+4.00%)
NVDA   544.31 (+0.57%)
BABA   290.38 (-1.22%)
CGC   14.11 (-1.47%)
MU   47.79 (+1.77%)
GE   6.17 (-0.96%)
AMD   84.89 (+3.54%)
T   28.47 (-0.14%)
F   6.71 (+0.75%)
ACB   4.72 (+1.51%)
GILD   63.48 (+0.46%)
NFLX   519.66 (+3.93%)
DIS   123.51 (-0.46%)
BA   166.86 (+0.97%)
BAC   24.04 (-0.21%)
S&P 500   3,380.24 (+0.51%)
DOW   27,814.12 (+0.12%)
QQQ   282.10 (+1.53%)
AAPL   116.65 (+0.73%)
MSFT   213.12 (+1.33%)
FB   267.53 (+2.15%)
GOOGL   1,486.55 (+1.43%)
AMZN   3,203.89 (+1.75%)
TSLA   446.18 (+4.00%)
NVDA   544.31 (+0.57%)
BABA   290.38 (-1.22%)
CGC   14.11 (-1.47%)
MU   47.79 (+1.77%)
GE   6.17 (-0.96%)
AMD   84.89 (+3.54%)
T   28.47 (-0.14%)
F   6.71 (+0.75%)
ACB   4.72 (+1.51%)
GILD   63.48 (+0.46%)
NFLX   519.66 (+3.93%)
DIS   123.51 (-0.46%)
BA   166.86 (+0.97%)
BAC   24.04 (-0.21%)
S&P 500   3,380.24 (+0.51%)
DOW   27,814.12 (+0.12%)
QQQ   282.10 (+1.53%)
AAPL   116.65 (+0.73%)
MSFT   213.12 (+1.33%)
FB   267.53 (+2.15%)
GOOGL   1,486.55 (+1.43%)
AMZN   3,203.89 (+1.75%)
TSLA   446.18 (+4.00%)
NVDA   544.31 (+0.57%)
BABA   290.38 (-1.22%)
CGC   14.11 (-1.47%)
MU   47.79 (+1.77%)
GE   6.17 (-0.96%)
AMD   84.89 (+3.54%)
T   28.47 (-0.14%)
F   6.71 (+0.75%)
ACB   4.72 (+1.51%)
GILD   63.48 (+0.46%)
NFLX   519.66 (+3.93%)
DIS   123.51 (-0.46%)
BA   166.86 (+0.97%)
BAC   24.04 (-0.21%)
Log in
NASDAQ:RKDA

Arcadia Biosciences Stock Forecast, Price & News

$2.88
+0.08 (+2.86 %)
(As of 10/1/2020 02:35 PM ET)
Add
Compare
Today's Range
$2.88
Now: $2.88
$2.88
50-Day Range
$2.54
MA: $3.10
$3.87
52-Week Range
$2.30
Now: $2.88
$6.63
Volume103 shs
Average Volume227,775 shs
Market Capitalization$30.82 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.58
Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. Arcadia Biosciences, Inc. has strategic collaborations with Dow AgroSciences and Ardent Mills LLC to develop and commercialize wheat varieties. The company was founded in 2002 and is headquartered in Davis, California.
Read More
Arcadia Biosciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural production - crops
Sub-IndustryN/A
Current SymbolNASDAQ:RKDA
CUSIPN/A
Phone530-756-7077

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.17 million
Book Value$0.96 per share

Profitability

Net Income$-28,810,000.00
Net Margins-1,973.82%

Miscellaneous

Employees44
Market Cap$30.82 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$2.88
+0.08 (+2.86 %)
(As of 10/1/2020 02:35 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RKDA News and Ratings via Email

Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions

How has Arcadia Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Arcadia Biosciences' stock was trading at $3.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RKDA shares have decreased by 9.1% and is now trading at $2.88.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Arcadia Biosciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Arcadia Biosciences
.

When is Arcadia Biosciences' next earnings date?

Arcadia Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Arcadia Biosciences
.

How were Arcadia Biosciences' earnings last quarter?

Arcadia Biosciences Inc (NASDAQ:RKDA) announced its earnings results on Thursday, August, 13th. The basic materials company reported ($0.71) earnings per share for the quarter, missing analysts' consensus estimates of ($0.61) by $0.10. The basic materials company had revenue of $0.28 million for the quarter, compared to analyst estimates of $1.54 million. Arcadia Biosciences had a negative return on equity of 175.11% and a negative net margin of 1,973.82%.
View Arcadia Biosciences' earnings history
.

When did Arcadia Biosciences' stock split? How did Arcadia Biosciences' stock split work?

Arcadia Biosciences shares reverse split on Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for RKDA?

2 brokers have issued 1 year price targets for Arcadia Biosciences' shares. Their forecasts range from $12.00 to $16.00. On average, they expect Arcadia Biosciences' stock price to reach $14.00 in the next year. This suggests a possible upside of 386.1% from the stock's current price.
View analysts' price targets for Arcadia Biosciences
.

Are investors shorting Arcadia Biosciences?

Arcadia Biosciences saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 483,900 shares, an increase of 10.0% from the August 15th total of 439,800 shares. Based on an average daily volume of 209,200 shares, the short-interest ratio is currently 2.3 days.
View Arcadia Biosciences' Short Interest
.

Who are some of Arcadia Biosciences' key competitors?

What other stocks do shareholders of Arcadia Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcadia Biosciences investors own include BioNano Genomics (BNGO), ADMA Biologics (ADMA), Zosano Pharma (ZSAN), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), OrganiGram (OGI), Pennsylvania R.E.I.T. (PEI), Novan (NOVN), Cannabics Pharmaceuticals (CNBX) and Enerplus (ERF).

Who are Arcadia Biosciences' key executives?

Arcadia Biosciences' management team includes the following people:
  • Mr. Rajendra Ketkar, Pres, CEO & Director (Age 65)
  • Mr. Matthew T. Plavan, CFO, Sec. & Pres of Arcadia Specialty Genomics (Age 55)
  • Ms. Sarah Reiter, Chief Commercial Officer (Age 47)
  • Dr. Randy Shultz Ph.D., Head of R&D
  • Dr. Zhongjin Lu Ph.D., Director of Product Devel. (Age 53)

When did Arcadia Biosciences IPO?

(RKDA) raised $66 million in an initial public offering (IPO) on Friday, May 15th 2015. The company issued 8,200,000 shares at $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

What is Arcadia Biosciences' stock symbol?

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

How do I buy shares of Arcadia Biosciences?

Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Arcadia Biosciences' stock price today?

One share of RKDA stock can currently be purchased for approximately $2.88.

How big of a company is Arcadia Biosciences?

Arcadia Biosciences has a market capitalization of $30.82 million and generates $1.17 million in revenue each year. The basic materials company earns $-28,810,000.00 in net income (profit) each year or ($3.37) on an earnings per share basis. Arcadia Biosciences employs 44 workers across the globe.

What is Arcadia Biosciences' official website?

The official website for Arcadia Biosciences is www.arcadiabio.com.

How can I contact Arcadia Biosciences?

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.